Onconetix, Inc. Adjustment of Warrants Granted for Services
Onconetix, Inc. (ONCO) reported Adjustment of Warrants Granted for Services of -$226.40 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2024-05-20
- Onconetix, Inc. adjustment of warrants granted for services for the quarter ending 2024-03-31 was -$226.40K, a 1986.67% decline year-over-year.
- Onconetix, Inc. adjustment of warrants granted for services for the quarter ending 2023-12-31 was $124.10K.
- Onconetix, Inc. adjustment of warrants granted for services for the quarter ending 2023-09-30 was -$4.00K.
- Onconetix, Inc. adjustment of warrants granted for services for the quarter ending 2023-06-30 was $2.00K.
- Onconetix, Inc. adjustment of warrants granted for services for fiscal 2023 was $134.10K.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$226.40K 10-Q · filed 2024-05-20 | -$102.30K derived: sum of 2 quarters · filed 2024-05-20 | -$106.30K derived: sum of 3 quarters · filed 2024-05-20 | -$104.30K derived: sum of 4 quarters · filed 2024-05-20 |
| 2023-12-31 | $124.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $120.10K derived: sum of 2 quarters · filed 2024-04-11 | $122.10K derived: sum of 3 quarters · filed 2024-04-11 | $134.10K 10-K · filed 2024-04-11 |
| 2023-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | -$2.00K derived: sum of 2 quarters · filed 2023-11-17 | $10.00K 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $14.00K 10-Q · filed 2023-10-20 | ||
| 2023-03-31 | $12.00K 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $14.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |